These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28468933)

  • 1. The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons.
    Ailanen L; Ruohonen ST; Vähätalo LH; Tuomainen K; Eerola K; Salomäki-Myftari H; Röyttä M; Laiho A; Ahotupa M; Gylling H; Savontaus E
    J Endocrinol; 2017 Jul; 234(1):57-72. PubMed ID: 28468933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice.
    Vähätalo LH; Ruohonen ST; Mäkelä S; Kovalainen M; Huotari A; Mäkelä KA; Määttä JA; Miinalainen I; Gilsbach R; Hein L; Ailanen L; Mattila M; Eerola K; Röyttä M; Ruohonen S; Herzig KH; Savontaus E
    Acta Physiol (Oxf); 2015 Apr; 213(4):902-19. PubMed ID: 25482272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance.
    Ruohonen ST; Pesonen U; Moritz N; Kaipio K; Röyttä M; Koulu M; Savontaus E
    Diabetes; 2008 Jun; 57(6):1517-25. PubMed ID: 18276767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y in noradrenergic neurons induces obesity in transgenic mouse models.
    Vähätalo LH; Ruohonen ST; Ailanen L; Savontaus E
    Neuropeptides; 2016 Feb; 55():31-7. PubMed ID: 26681068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes.
    Yang CH; Ann-Onda D; Lin X; Fynch S; Nadarajah S; Pappas EG; Liu X; Scott JW; Oakhill JS; Galic S; Shi Y; Moreno-Asso A; Smith C; Loudovaris T; Levinger I; Eizirik DL; Laybutt DR; Herzog H; Thomas HE; Loh K
    Mol Metab; 2022 Jan; 55():101413. PubMed ID: 34890851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin normalizes the structural changes in glycogen preceding prediabetes in mice overexpressing neuropeptide Y in noradrenergic neurons.
    Ailanen L; Bezborodkina NN; Virtanen L; Ruohonen ST; Malova AV; Okovityi SV; Chistyakova EY; Savontaus E
    Pharmacol Res Perspect; 2018 Apr; 6(2):e00389. PubMed ID: 29541475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet-induced obesity in mice overexpressing neuropeptide y in noradrenergic neurons.
    Ruohonen ST; Vähätalo LH; Savontaus E
    Int J Pept; 2012; 2012():452524. PubMed ID: 23118773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons.
    Ruohonen ST; Savontaus E; Rinne P; Rosmaninho-Salgado J; Cavadas C; Ruskoaho H; Koulu M; Pesonen U
    Neuroendocrinology; 2009; 89(3):351-60. PubMed ID: 19122447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.
    Lin EJ; Sainsbury A; Lee NJ; Boey D; Couzens M; Enriquez R; Slack K; Bland R; During MJ; Herzog H
    Endocrinology; 2006 Nov; 147(11):5094-101. PubMed ID: 16873543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Neuropeptide Y Overexpression on the Mouse Model of Doxorubicin-Induced Cardiotoxicity.
    Mattila M; Söderström M; Ailanen L; Savontaus E; Savontaus M
    Cardiovasc Toxicol; 2020 Jun; 20(3):328-338. PubMed ID: 31811615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripherally Administered Y
    Ailanen L; Vähätalo LH; Salomäki-Myftari H; Mäkelä S; Orpana W; Ruohonen ST; Savontaus E
    Front Pharmacol; 2018; 9():319. PubMed ID: 29674968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons.
    Vähätalo LH; Ruohonen ST; Mäkelä S; Ailanen L; Penttinen AM; Stormi T; Kauko T; Piscitelli F; Silvestri C; Savontaus E; Di Marzo V
    Nutr Diabetes; 2015 Apr; 5(4):e151. PubMed ID: 25915740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation.
    Naveilhan P; Svensson L; Nyström S; Ekstrand AJ; Ernfors P
    Peptides; 2002 Jun; 23(6):1087-91. PubMed ID: 12126735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the involvement of neuropeptide Y in the antidepressant effect of imipramine in type 2 diabetes.
    Nakhate KT; Yedke SU; Bharne AP; Subhedar NK; Kokare DM
    Brain Res; 2016 Sep; 1646():1-11. PubMed ID: 27208493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury.
    Ruohonen ST; Abe K; Kero M; Toukola L; Ruohonen S; Röyttä M; Koulu M; Pesonen U; Zukowska Z; Savontaus E
    Peptides; 2009 Apr; 30(4):715-20. PubMed ID: 19135490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY.
    Mashiko S; Ishihara A; Iwaasa H; Sano H; Oda Z; Ito J; Yumoto M; Okawa M; Suzuki J; Fukuroda T; Jitsuoka M; Morin NR; MacNeil DJ; Van der Ploeg LH; Ihara M; Fukami T; Kanatani A
    Endocrinology; 2003 May; 144(5):1793-801. PubMed ID: 12697685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding.
    Kaga T; Inui A; Okita M; Asakawa A; Ueno N; Kasuga M; Fujimiya M; Nishimura N; Dobashi R; Morimoto Y; Liu IM; Cheng JT
    Diabetes; 2001 May; 50(5):1206-10. PubMed ID: 11334428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
    Lin EJ; Young D; Baer K; Herzog H; During MJ
    Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Over-Expression of Neuropeptide Y in Hypothalamic Paraventricular Nucleus Contributes to Adipose Tissue Insulin Resistance Partly via the Y5 Receptor.
    Long M; Zhou J; Li D; Zheng L; Xu Z; Zhou S
    PLoS One; 2015; 10(5):e0126714. PubMed ID: 25993471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.